• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2719757
  • December 2013
  • Region: Global
  • 93 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Cord Blood America, Inc.
  • Cordlife Group Ltd.
  • Cryo-Save Group AV
  • NeoStem, Inc.
  • ViaCord, Inc.
  • MORE

'Cord Blood Banking Services Market (Private and Public Cord Blood Banks) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

Umbilical cord blood banking or cord blood banking is the practice of preserving blood from the umbilical cord for future use. Such preserved cord blood is used in medical therapies in similar fashion as that of stem cells derived from bone marrow. Cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions. This report studies the current market condition and future potential for cord blood banking services.

Based on the types of banks that store cord blood, the global cord blood banking services market is classified into public cord blood banks and private cord blood banks. This report studies the current market competition and future growth of private and public cord blood banks in terms of revenue generation of such services (USD Million) for the period 2011 - 2019. The report also demonstrates the compounded annual growth rate (CAGR %) for each such service type for the forecast period 2013 – 2019 while considering 2012 READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cord Blood America, Inc.
  • Cordlife Group Ltd.
  • Cryo-Save Group AV
  • NeoStem, Inc.
  • ViaCord, Inc.
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Global Cord Blood Banking Services Market Overview
3.1 Market Trends and Future Outlook
3.1.1 Differentiation of Hematopoietic Progenitor Cell to Create Lineage of Blood Cells
3.2 Growth Drivers
3.2.1 Advancement in Cord Blood Banking Technology
3.2.2 Rising Parental Awareness Will In-Turn Increase the Acceptance
3.3 Restraints
3.3.1 Lack of Cord Blood Units
3.3.2 Cost Constraints
3.3.3 Accreditation Requirements
3.3.4 Strict Laboratory and Storage Requirements
3.4 Opportunities
3.4.1 Increase in Applications of Cord Blood Cells in Treatment of Various Therapies
3.4.2 Presence of Untapped Opportunities in Emerging Economies
3.5 Regulatory Status for Using Cord Blood Banking
3.5.1 American Association of Blood Banks (AABB)
3.5.2 American Association of Tissue Banks (AATB)
3.5.3 Clinical Laboratory Improvement Amendments (CLIA)
3.5.4 Foundation for the Accreditation of Cellular Therapy (FACT)
3.5.5 FDA Biologics License Application (FDA BLA)
3.5.6 Human Tissue Authority (HTA) – UK
3.5.7 International Organization for Standardization (ISO)
3.5.8 Joint Accreditation Committee - ISCT – EBMT (JACIE)
3.5.9 NetCord
3.6 Current and Future Medical Conditions Treatable with Cord Blood Transplant
3.6.1 Standard Therapies
3.6.1.1 Leukemias
3.6.1.2 Lymphomas
3.6.1.3 Blood Cell Proliferation Disorders
3.6.1.4 Transplants for Inherited Diseases Affecting Immune System and Related Organs
3.6.1.5 Transplants for Inherited Metabolic Conditions
3.6.2 Stem Cell Therapies in Clinical Trials
3.6.2.1 Auto-Immune Diseases
3.6.2.2 Cardiovascular Diseases
3.6.2.3 Neurologic Diseases
3.6.2.4 Orthopedic Diseases
3.6.2.5 Stem Cells & Gene Therapy for Inherited Disorders
3.6.2.6 Becker Muscular Dystrophy
3.6.2.7 Stem Cell Transplantation for Additional Inherited Disorders
3.6.2.8 Stem Cell Transplantation for New Indications
3.6.3 Experimental Treatments
3.6.4 Clinical Trials with Stem Cells from Cord Tissue
3.7 Porter’s Five Forces Analysis for the Global Cord Blood Banking Services Market
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Threat of New Entrants
3.7.4 Threat of Substitutes
3.7.5 Competitive Rivalry
3.8 Market Attractiveness Analysis of the Global Cord Blood Banking Services Market, 2012

Chapter 4 Global Cord Blood Banking Services Market, by Storage Options, 2011 – 2019 (USD Billion)
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cord Blood Banking Services Market, by Storage Options, 2011 – 2019 (USD Billion)
4.2 Comparison: Private and Public Cord Blood Banks
4.2.1 Private Cord Blood Banks
4.2.1.1 Global Private Cord Blood Banks Market Revenue, 2011 – 2019 (USD Billion)
4.2.2 Public Cord Blood Banks
4.2.2.1 Global Public Cord Blood Banks Market Revenue, 2011 – 2019 (USD Billion)

Chapter 5 Global Cord Blood Banking Services Market, by Geography, Size and Forecast, 2011 – 2019 (USD Billion)
5.1 Overview – Current Market Scenario and Future Market Trends
5.2 North America
5.2.1 North America Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
5.2.2 Private Cord Blood Banking
5.2.2.1 North America Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.2.3 Public Cord Blood Banking
5.2.3.1 North America Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.2.4 U.S. - Current Status and Future Scenario
5.2.5 Canada - Current Status and Future Scenario
5.3 Europe
5.3.1 Private Cord Blood Banking
5.3.1.1 Europe Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.3.2 Public Cord Blood Banking
5.3.2.1 Europe Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.3.3 U.K. - Current Status and Future Scenario
5.3.4 Spain - Current Status and Future Scenario
5.3.5 France - Current Status and Future Scenario
5.3.6 Germany - Current Status and Future Scenario
5.3.7 Italy - Current Status and Future Scenario
5.3.8 Belgium - Current Status and Future Scenario
5.4 Asia-Pacific
5.4.1 Asia-Pacific Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
5.4.2 Private Cord Blood Banking
5.4.2.1 Asia-Pacific Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.4.3 Public Cord Blood Banking
5.4.3.1 Asia-Pacific Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.4.4 India - Current Status and Future Scenario
5.4.5 China - Current Status and Future Scenario
5.4.6 Japan - Current Status and Future Scenario
5.4.7 Australia - Current Status and Future Scenario
5.4.8 New Zealand - Current Status and Future Scenario
5.4.9 Philippines - Current Status and Future Scenario
5.5 Rest of the World (RoW)
5.5.1 RoW Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
5.5.2 Private Cord Blood Banking
5.5.2.1 RoW Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.5.3 Public Cord Blood Banking
5.5.3.1 RoW Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
5.5.4 Brazil - Current Status and Future Scenario
5.5.5 Argentina - Current Status and Future Scenario
5.5.6 Middle Eastern Countries - Current Status and Future Scenario
5.5.7 Russia - Current Status and Future Scenario

Chapter 6 Recommendations

Chapter 7 Company Profiles
7.1 China Cord Blood Corporation
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Recent Development
7.2 Cord Blood America, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.2.4 Recent Developments
7.3 Cord Blood Registry Systems, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Cordlife Group Ltd.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Cryo-Cell International, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.5.4 Partnerships and Agreements
7.5.5 Recent Developments
7.6 Cryo-Save Group AV
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
7.6.4 Recent Developments
7.7 NeoStem, Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategies
7.7.4 Recent Developments
7.8 ViaCord, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies
7.8.4 Collaboration
7.8.5 Recent Developments

List of Figures

FIG. 1 Cord Blood Banking Services: Market Segmentation
FIG. 2 Global Cord Blood Banking Services Market, by Geography, 2012
FIG. 3 Differentiation of Hematopoietic Progenitor Cell to Create Lineage of Blood Cells
FIG. 4 Porter’s Five Forces Analysis: Global Cord Blood Banking Services Market
FIG. 5 Market Attractiveness Analysis: Cord Blood Banking Services Market, 2012
FIG. 6 Global Private Cord Blood Banks Market Revenue, 2011 – 2019 (USD Billion)
FIG. 7 Global Public Cord Blood Banks Market Revenue, 2011 – 2019 (USD Billion)
FIG. 8 North America Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 9 North America Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 10 Europe Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 11 Europe Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 12 Asia-Pacific Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 13 Asia-Pacific Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 14 RoW Private Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 15 RoW Public Cord Blood Banking Services Market Revenue, 2011 – 2019 (USD Billion)
FIG. 16 China Cord Blood Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 17 Cord Blood America, Inc.: Annual Revenue, 2010–2012 (USD Million)
FIG. 18 Cordlife Group Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 19 Cryo-Cell International, Inc.: Annual Revenue, 2010–2012 (USD Million)
FIG. 20 Cryo-Save Group AV: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 21 NeoStem, Inc.: Annual Revenue, 2010–2012 (USD Million)

List of Tables

TABLE 1 Standard Therapies Treatable with Cord Blood Transplant: Leukemias
TABLE 2 Standard Therapies Treatable with Cord Blood Transplant: Lymphomas
TABLE 3 Standard Therapies Treatable with Cord Blood Transplant: Blood Cell Proliferation Disorders
TABLE 4 Standard Therapies Treatable with Cord Blood Transplant: Transplants for Inherited Diseases Affecting Immune System and Related Organs
TABLE 5 Standard Therapies Treatable with Cord Blood Transplant: Transplants for Inherited Metabolic Conditions
TABLE 6 Stem Cell Therapies in Clinical Trials: Auto-Immune Diseases
TABLE 7 Stem Cell Therapies in Clinical Trials: Cardiovascular Diseases
TABLE 8 Stem Cell Therapies in Clinical Trials: Neurologic Diseases
TABLE 9 Stem Cell Therapies in Clinical Trials: Orthopedic Diseases
TABLE 10 Stem Cell Therapies in Clinical Trials: Stem Cells & Gene Therapy for Inherited Disorders
TABLE 11 Stem Cell Therapies in Clinical Trials: Becker Muscular Dystrophy
TABLE 12 Stem Cell Therapies in Clinical Trials: Stem Cell Transplantation for Additional Inherited Disorders
TABLE 13 Stem Cell Therapies in Clinical Trials: Stem Cell Transplantation for New Indications
TABLE 14 Experimental Treatments
TABLE 15 Clinical Trials with Stem Cells from Cord Tissue
TABLE 16 Global Cord Blood Banking Services Market, by Storage Options, 2011 – 2019 (USD Billion)
TABLE 17 Comparison: Private and Public Cord Blood Banks
TABLE 18 Global Cord Blood Banking Services Market Revenue, by Geography, 2011 – 2019 (USD Billion)
TABLE 19 North America Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
TABLE 20 Europe Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
TABLE 21 Asia-Pacific Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)
TABLE 22 RoW Cord Blood Banking Services Market Revenue, by Storage Options, 2011 – 2019 (USD Billion)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cord Blood America, Inc.
  • Cordlife Group Ltd.
  • Cryo-Save Group AV
  • NeoStem, Inc.
  • ViaCord, Inc.
  • MORE

Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and white blood cells. Researchers have discovered that stem cells can be used for the treatment of 80 different diseases including thalassemia, sickle cell anemia, leukemia diabetes and cardiac diseases. The major sources for stem cell banking are storing of peripheral blood and bone marrow, umbilical cord blood (UCB) is by far considered as the largest component for hematopoietic stem cells. Donated cord blood has become one of the most reliable sources for stem cells over the last decade and is thus considered as a valuable biological resource. The chances of cord blood sample matching with the patients that is closely in relation to the baby whose sample is to be used are 39% more than the sample obtained from the public banks. Cord blood banking services is a promising and a fast growing segment in the field of next generation stem cell therapy and national cord blood registries are changing perception and look of the industry.

Cord blood can be stored in either of the two ways, banking in private cord blood banks or donating in public cord blood banks. Private cord blood banks collect and store cord blood for the use of baby and close family members only. Collection and storage of the cord blood is charged to the parents of the baby. And secondly the cord blood can be donated to a public bank where the cord blood unit is stored and is publicly available for the suitable match. All the charges of storage and maintenance of the cord blood unit obtained from public bank are taken from the patient or patient’s family for whom the unit is going to utilize in transplantation process. Though globally the number of private cord blood banks are more as compared to public banks, number of units stored in public banks are more than units of cord blood banks stored in private banks globally.

The amount of stem cells required for the transplantation process vary depending on person’s weight and age. The major disadvantage of cord blood storing in private cord blood bank is that the single unit of the cord blood contains insufficient amount of stem cells and becomes difficult to treat adults using stem cell transplant. On the other hand, cord blood units stored in public banks is available to any patient matching with the blood unit sample stored in public banks globally. And hence multiple units can be utilized for single patient to meet the requirement of the stem cells in transplantation procedure.

Taking inability of the privately stored cord blood units to meet the requirement of the amount of stem cell into consideration healthcare professionals are focusing on enhancing cord blood inventory in public banks so that demand for the cord blood units can be matched. Gynecologists, pediatricians and obstetricians recommend to store cord blood in private banks only if the family has history of the disease that can be treated using stem cells.

Geographically North America is dominating the global cord blood banking services market followed by Europe. Governments taking initiative to regulate the cord blood banking industry in the country and implementation of hybrid model to reduce the attrition between private cord blood banking and public cord blood banks is driving the growth of cord blood banking services market. Asia-Pacific is lucrative market owing to increased cord blood banking in countries like China and India. Contribution of Asian countries in banking cord blood is expected to increase further as medical tourism industry is booming in this region. Growing awareness about cord blood banking and treatments that can cure blood borne diseases using stem cells in cord blood is increasing. Countries like France, Italy and UAE have banned private banking of the cord blood. Governments of these countries are actively participating in establishing nationwide public banks to enhance the inventory of the cord blood units.

Note: Product cover images may vary from those shown

- China Cord Blood Corporation
- Cord Blood America, Inc.
- Cord Blood Registry Systems, Inc.
- Cordlife Group Ltd.
- Cryo-Cell International, Inc.
- Cryo-Save Group AV
- NeoStem, Inc.
- ViaCord, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos